VALIANTLAB — Valiant Laboratories Cashflow Statement
0.000.00%
Last trade - 00:00- IN₹4.18bn
- IN₹4.31bn
- IN₹2.37bn
Annual cashflow statement for Valiant Laboratories, fiscal year end - March 31st, INR millions except per share, conversion factor applied.
2022 March 31st | 2023 March 31st | 2024 March 31st | 2025 March 31st | 2026 March 31st | |
|---|---|---|---|---|---|
| Period Length: | 12 M | 12 M | 12 M | 12 M | 12 M |
| Source: | ARS | PROSPECTUS | ARS | ARS | PRESS |
| Standards: | IAS | IAS | IAS | IAS | — |
| Status: | Final | Final | Final | Final | Final |
| Net Income/Starting Line | 302 | 381 | -7.7 | -15.1 | 7.68 |
| Depreciation | |||||
| Non-Cash Items | -4.65 | -0.07 | 0.778 | 22 | 8.51 |
| Unusual Items | |||||
| Other Non-Cash Items | |||||
| Changes in Working Capital | -166 | 164 | 6.12 | -14.6 | -181 |
| Change in Accounts Receivable | |||||
| Change in Inventories | |||||
| Change in Other Assets | |||||
| Change in Accounts Payable | |||||
| Change in Other Liabilities | |||||
| Other Operating Cash Flow | |||||
| Cash from Operating Activities | 148 | 561 | 18.9 | 13.1 | -104 |
| Capital Expenditures | -58.8 | -377 | -459 | -1,139 | -342 |
| Purchase of Fixed Assets | |||||
| Other Investing Cash Flow Items | -95.1 | -175 | -980 | 611 | 415 |
| Sale of Fixed Assets | |||||
| Sale/Maturity of Investment | |||||
| Purchase of Investments | |||||
| Other Investing Cash Flow | |||||
| Cash from Investing Activities | -154 | -552 | -1,439 | -528 | 72.5 |
| Financing Cash Flow Items | -0.584 | -0.25 | -0.778 | -5.01 | 672 |
| Other Financing Cash Flow | |||||
| Net Issuance / Retirement of Stock | |||||
| Net Issuance / Retirement of Debt | |||||
| Cash from Financing Activities | 208 | -9.34 | 1,524 | 447 | 17.9 |
| Beginning Cash Balance | |||||
| Ending Cash Balance | |||||
| Net Change in Cash | 201 | -0.51 | 105 | -68 | -13.9 |